(R)-2-amino-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-ethylphenyl)-N-isopropylnicotinamide

ID: ALA4857782

PubChem CID: 163196452

Max Phase: Preclinical

Molecular Formula: C25H26F2N4O3

Molecular Weight: 468.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1

Standard InChI:  InChI=1S/C25H26F2N4O3/c1-4-14-9-19(31-25(34)22(32)15-7-17(26)11-18(27)8-15)5-6-20(14)16-10-21(23(28)29-12-16)24(33)30-13(2)3/h5-13,22,32H,4H2,1-3H3,(H2,28,29)(H,30,33)(H,31,34)/t22-/m1/s1

Standard InChI Key:  YNDQMKBAYRFBMW-JOCHJYFZSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
   28.3279  -21.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3267  -22.2357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0348  -22.6447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7444  -22.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7416  -21.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0330  -21.0073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6221  -21.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6233  -20.1896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9163  -19.7813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.2077  -20.1901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2106  -21.0115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9181  -21.4161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4994  -19.7826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5025  -21.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7932  -21.0179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.5056  -22.2410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4528  -22.6427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.1599  -22.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8682  -22.6405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1586  -21.4158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.5753  -22.2308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2823  -22.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9889  -22.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9881  -21.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2747  -21.0052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5711  -21.4166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6971  -22.6384    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   33.2706  -20.1880    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.8695  -23.4577    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.2148  -22.6469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2179  -23.4641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9210  -22.2357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6187  -22.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6181  -23.4609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  1  7  1  0
 10 13  1  0
 14 15  2  0
 14 16  1  0
 11 14  1  0
  4 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 23 27  1  0
 25 28  1  0
 19 29  1  1
 16 30  1  0
 30 31  1  0
 30 32  1  0
  2 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4857782

    ---

Associated Targets(Human)

EIF2AK3 Tchem Eukaryotic translation initiation factor 2-alpha kinase 3 (635 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EIF2S1 Tchem Eukaryotic translation initiation factor 2 subunit 1 (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AXL Tchem Tyrosine-protein kinase receptor UFO (3469 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSF1R Tclin Macrophage colony stimulating factor receptor (5179 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DDR1 Tchem Epithelial discoidin domain-containing receptor 1 (1050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK12 Tchem MAP kinase p38 gamma (2776 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RIPK1 Tchem Receptor-interacting serine/threonine-protein kinase 1 (1548 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TEK Tclin Tyrosine-protein kinase TIE-2 (3348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK2 Tclin Neurotrophic tyrosine kinase receptor type 2 (3279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.50Molecular Weight (Monoisotopic): 468.1973AlogP: 3.98#Rotatable Bonds: 7
Polar Surface Area: 117.34Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.01CX Basic pKa: 5.01CX LogP: 4.27CX LogD: 4.26
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -0.94

References

1. Calvo V, Surguladze D, Li AH, Surman MD, Malibhatla S, Bandaru M, Jonnalagadda SK, Adarasandi R, Velmala M, Singireddi DRP, Velpuri M, Nareddy BR, Sastry V, Mandati C, Guguloth R, Siddiqui S, Patil BS, Chad E, Wolfley J, Gasparek J, Feldman K, Betzenhauser M, Wiens B, Koszelak-Rosenblum M, Zhu G, Du H, Rigby AC, Mulvihill MJ..  (2021)  Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors.,  43  [PMID:33895276] [10.1016/j.bmcl.2021.128058]

Source